Revelation Biosciences, Inc. filed its 10-K on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, Baker Tilly, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | +5.69% | -12.56% | -87.02% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-87.02% | 3.01M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- REVB Stock
- News Revelation Biosciences, Inc.
- Revelation Biosciences, Inc. Auditor Raises 'Going Concern' Doubt